Application of Magnetic Resonance Fat-Free Imaging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00944476|
Recruitment Status : Terminated (Software issues not resolved.)
First Posted : July 23, 2009
Last Update Posted : May 15, 2014
|Condition or disease||Intervention/treatment|
|Sarcoma||Procedure: Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam|
|Study Type :||Observational|
|Actual Enrollment :||2 participants|
|Official Title:||Application of Magnetic Resonance Fat-Free Imaging|
|Study Start Date :||July 2009|
|Primary Completion Date :||May 2014|
Pts/volunteers getting regular MRI exam
Fat-free MRI images utilizing standard magnetization transfer imaging will be acquired on 10 patients known or suspected sarcoma of the of the extremity or trunk, in addition to their traditional clinical MRI. In addition, we will perform the same scans on 4 volunteers who have no history of sarcoma.
Procedure: Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam
In addition to the traditional MRI exam for clinical use, a fat-free MRI based on standard magnetization transfer magnetic resonance imaging will be acquired. Pts will spend 20 extra minutes and 20 minutes total for volunteers in the MRI scanner. Patients/volunteers will complete the MR Screening Questionnaire before the MRI exam.
- To determine if our magnetization transfer fat-free imaging methods produce fat suppression images of sarcoma that are better, equal to or less in quality than fat-suppressed T2-weighted MRI images. [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00944476
|United States, New York|
|Memorial Sloan-Kettering CancerCenter|
|New York, New York, United States, 10065|
|Principal Investigator:||Samuel Singer, MD||Memorial Sloan Kettering Cancer Center|